Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiofrequency ablation of hepatic Hodgkin lymphoma.
Rusconi C, Rampoldi AG, Ravelli E, Nosari AM, Zilioli VR, Vanzulli A, Morra E. Rusconi C, et al. Leuk Lymphoma. 2009 Jan;50(1):141-4. doi: 10.1080/10428190802524837. Leuk Lymphoma. 2009. PMID: 19152173 No abstract available.
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma.
Corso A, Mangiacavalli S, Nosari A, Castagnola C, Zappasodi P, Cafro AM, Astori C, Bonfichi M, Varettoni M, Rusconi C, Troletti D, Pascutto C, Morra E, Lazzarino M; HOST Group. Corso A, et al. Among authors: rusconi c. Bone Marrow Transplant. 2005 Dec;36(11):951-4. doi: 10.1038/sj.bmt.1705166. Bone Marrow Transplant. 2005. PMID: 16184179 Clinical Trial.
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.
Zinzani PL, Broccoli A, Gioia DM, Castagnoli A, Ciccone G, Evangelista A, Santoro A, Ricardi U, Bonfichi M, Brusamolino E, Rossi G, Anastasia A, Zaja F, Vitolo U, Pavone V, Pulsoni A, Rigacci L, Gaidano G, Stelitano C, Salvi F, Rusconi C, Tani M, Freilone R, Pregno P, Borsatti E, Sacchetti GM, Argnani L, Levis A. Zinzani PL, et al. Among authors: rusconi c. J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16. J Clin Oncol. 2016. PMID: 26884559 Free article. Clinical Trial.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S, Ferretti VV, Rusconi C, Rossi A, Fogazzi S, Baldini L, Pioltelli P, Balzarotti M, Farina L, Ferreri AJM, Laszlo D, Speziale V, Varettoni M, Sciarra R, Morello L, Tedeschi A, Frigeni M, Defrancesco I, Zerbi C, Flospergher E, Nizzoli ME, Morra E, Arcaini L; “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup). Rattotti S, et al. Among authors: rusconi c. Hematol Oncol. 2019 Apr;37(2):160-167. doi: 10.1002/hon.2575. Epub 2019 Feb 22. Hematol Oncol. 2019. PMID: 30726562 Clinical Trial.
Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience.
Zilioli VR, Muzi C, Minga P, Codega P, Crucitti L, Meli E, Esposito A, Panico C, Rusconi C, Cairoli R. Zilioli VR, et al. Among authors: rusconi c. Int J Hematol Oncol. 2020 Feb 28;9(1):IJH23. doi: 10.2217/ijh-2020-0001. Int J Hematol Oncol. 2020. PMID: 32382409 Free PMC article.
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.
Visco C, Di Rocco A, Evangelista A, Quaglia FM, Tisi MC, Morello L, Zilioli VR, Rusconi C, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Marin-Niebla A, McCulloch R, Gini G, Perrone T, Nassi L, Pennese E, Stefani PM, Cox MC, Bozzoli V, Fabbri A, Polli V, Ferrero S, Celis MIA, Sica A, Petrucci L, Arcaini L, Rule S, Krampera M, Vitolo U, Balzarotti M. Visco C, et al. Among authors: rusconi c. Leukemia. 2021 Mar;35(3):787-795. doi: 10.1038/s41375-020-01013-3. Epub 2020 Aug 11. Leukemia. 2021. PMID: 32782382
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.
Visco C, Di Rocco A, Evangelista A, Quaglia FM, Tisi MC, Morello L, Zilioli VR, Rusconi C, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Marin-Niebla A, McCulloch R, Gini G, Perrone T, Nassi L, Pennese E, Stefani PM, Cox MC, Bozzoli V, Fabbri A, Polli V, Ferrero S, De Celis MIA, Sica A, Petrucci L, Arcaini L, Rule S, Krampera M, Vitolo U, Balzarotti M. Visco C, et al. Among authors: rusconi c. Leukemia. 2021 Mar;35(3):932. doi: 10.1038/s41375-020-01119-8. Leukemia. 2021. PMID: 33483620 No abstract available.
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.
Rusconi C, Barone A, Visentin A, Bianchi B, Zilioli VR, Bernardelli A, Iadecola S, Olivari E, Rossi FG, Gotti M, Cecchetti C, Puccini B, Franceschetti S, Molteni A, Steffanoni S, Marino F, Vanazzi A, Guidetti A, Merli M, Mazzon F, Marchetti A, Cellini A, Muzi C, Miceli R, Visco C, Re A, Corradini P. Rusconi C, et al. Leuk Lymphoma. 2025 Jan 11:1-9. doi: 10.1080/10428194.2024.2446609. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39797589
246 results